Kristian Villumsen

Kristian Villumsen has served as President and CEO of Coloplast since 2018, leading the Danish medical device company to consistent high-single-digit organic growth and a market capitalization exceeding $30 billion. Coloplast specializes in what it calls "intimate healthcare" — medical products for conditions that are deeply personal and often stigmatized, but that affect millions of people worldwide. Coloplast operates in four business areas: Ostomy Care (bags and accessories for people who have had bowel or bladder diversions through surgery), Continence Care (catheters for people with urinary conditions), Wound and Skin Care (advanced wound dressings and skin care products), and Interventional Urology (through the Laborie Medical Technologies acquisition). The company's products are predominantly single-use, creating strong recurring demand from patients who need supplies continuously. Villumsen has driven growth through product innovation (particularly the SenSura Mio and Brava lines in ostomy), geographic expansion (emerging markets), and the Laborie acquisition that added interventional urology capabilities. Key stock drivers include organic revenue growth (targeting 7-9% annually), emerging market penetration, Laborie integration, reimbursement policies in key markets, competitive dynamics with Hollister and Convatec, and the demographic tailwind of aging populations requiring more intimate healthcare products.